CDH10 Target and Research Tools for Cancer Studies

Cadherin-10 (CDH10) is a member of the classical cadherin family and plays an important role in cell-cell adhesion, tissue organization, and nervous system development. Through its calcium-dependent extracellular domains, CDH10 regulates cell interactions, migration, and structural stability. Emerging evidence suggests that dysregulated CDH10 expression or signaling is associated with pathological conditions, including cancer, positioning CDH10 as a promising cancer-related target.

As a representative cadherin family target, CDH10 has attracted increasing attention in drug discovery and translational research. To date, multiple CDH10-associated therapeutic research programs are underway worldwide, spanning monoclonal antibodies, antibody drug conjugates (ADCs), and combination strategies targeting complementary signaling pathways. These programs are driven by multinational pharmaceutical companies, biotechnology firms, and innovative startups, with research focusing on tumor cell adhesion, invasion, migration, and tumor microenvironment modulation. Exploring more information of Cadherin Family…

To support CDH10 target research and antibody development, DIMA BIOTECH offers a series of products and services, including multi-species recombinant CDH10 proteins, domain-specific CDH10 proteins, stable CDH10-expressing cell lines, and live-cell flow cytometry-validated antibodies, enabling efficient target validation, antibody screening, epitope mapping, and functional cell-based assays.